$APTO
Aptose Biosciences Inc.

2022 Q3 Form 10-Q Financial Statement

#000117184322005260 Filed on August 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.424M $3.311M $4.106M
YoY Change -5.05% -8.59% -28.72%
% of Gross Profit
Research & Development $6.578M $7.341M $20.20M
YoY Change -14.77% -25.33% 125.18%
% of Gross Profit
Depreciation & Amortization $30.00K $30.00K $44.00K
YoY Change -16.67% -14.29% 46.67%
% of Gross Profit
Operating Expenses $10.03M $10.67M $24.35M
YoY Change -11.74% -20.87% 64.96%
Operating Profit
YoY Change
Interest Expense $249.0K $108.0K $24.00K
YoY Change 857.69% 500.0% -52.0%
% of Operating Profit
Other Income/Expense, Net $249.0K $108.0K
YoY Change 857.69% 500.0%
Pretax Income -$9.777M -$10.57M -$24.32M
YoY Change -13.73% -21.57% 65.36%
Income Tax
% Of Pretax Income
Net Earnings -$9.777M -$10.57M -$24.32M
YoY Change -13.73% -21.57% 65.32%
Net Earnings / Revenue
Basic Earnings Per Share -$0.11 -$0.11 -$0.27
Diluted Earnings Per Share -$0.11 -$0.11 -$271.6K
COMMON SHARES
Basic Shares Outstanding 92.29M 92.24M 88.95M
Diluted Shares Outstanding 6.153M 6.150M

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.39M $62.41M $79.13M
YoY Change -41.75% -39.61% -35.35%
Cash & Equivalents $27.99M $40.03M $39.11M
Short-Term Investments $27.40M $22.38M $40.01M
Other Short-Term Assets $346.0K $121.0K $133.0K
YoY Change 164.12% -14.18% 3.1%
Inventory
Prepaid Expenses $838.0K $1.663M $2.476M
Receivables
Other Receivables
Total Short-Term Assets $56.58M $64.19M $81.74M
YoY Change -41.23% -39.04% -34.65%
LONG-TERM ASSETS
Property, Plant & Equipment $251.0K $281.0K $323.0K
YoY Change -28.9% 35.1% 23.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $471.0K $612.0K $788.0K
YoY Change -49.46% -32.45% -33.56%
TOTAL ASSETS
Total Short-Term Assets $56.58M $64.19M $81.74M
Total Long-Term Assets $471.0K $612.0K $788.0K
Total Assets $57.05M $64.81M $82.53M
YoY Change -41.31% -38.98% -34.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.416M $2.393M $1.699M
YoY Change 48.22% -17.88% -21.74%
Accrued Expenses $7.547M $6.521M $6.016M
YoY Change 21.96% 52.25% 46.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.23M $9.312M $8.174M
YoY Change 23.29% 20.86% 19.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.000K $3.000K $115.0K
YoY Change -99.54% -99.07% -77.0%
Total Long-Term Liabilities $1.000K $3.000K $115.0K
YoY Change -99.54% -99.07% -77.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.23M $9.312M $8.174M
Total Long-Term Liabilities $1.000K $3.000K $115.0K
Total Liabilities $10.23M $9.315M $8.289M
YoY Change 20.15% 16.06% 12.82%
SHAREHOLDERS EQUITY
Retained Earnings -$454.3M -$444.6M -$422.5M
YoY Change 14.1% 14.92% 18.3%
Common Stock $437.5M $437.4M $437.4M
YoY Change 1.79% 1.78% 1.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $46.81M $55.49M $74.24M
YoY Change
Total Liabilities & Shareholders Equity $57.05M $64.81M $82.53M
YoY Change -41.31% -38.98% -34.64%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$9.777M -$10.57M -$24.32M
YoY Change -13.73% -21.57% 65.32%
Depreciation, Depletion And Amortization $30.00K $30.00K $44.00K
YoY Change -16.67% -14.29% 46.67%
Cash From Operating Activities -$6.979M -$7.047M -$16.04M
YoY Change -13.4% -20.15% 55.01%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $24.00K -$14.00K
YoY Change -100.0% -53.33%
Acquisitions
YoY Change
Other Investing Activities -$5.078M $10.09M -$20.00M
YoY Change 126850.0% 101.64% -171.44%
Cash From Investing Activities -$5.078M $10.07M -$20.01M
YoY Change 2644.86% 101.36% -171.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $29.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $21.00K $29.00K 66.00K
YoY Change -65.88% 65.0%
NET CHANGE
Cash From Operating Activities -$6.979M -$7.047M -16.04M
Cash From Investing Activities -$5.078M $10.07M -20.01M
Cash From Financing Activities $21.00K $29.00K 66.00K
Net Change In Cash -$12.04M $3.043M -35.99M
YoY Change 46.01% -181.36% -303.9%
FREE CASH FLOW
Cash From Operating Activities -$6.979M -$7.047M -$16.04M
Capital Expenditures $0.00 $24.00K -$14.00K
Free Cash Flow -$6.979M -$7.071M -$16.03M
YoY Change -15.3% -19.88% 55.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92257227
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
92257227
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92215024
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
92215024
CY2022Q2 apto Employee Stock Purchase Plan Stock Purchase Price Percent
EmployeeStockPurchasePlanStockPurchasePricePercent
0.85 pure
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M2J 4R3
CY2021 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
dei Document Type
DocumentType
10-Q
apto Weighted Average Number Of Shares Outstanding Basic And Diluted Total
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedTotal
88915000
CY2022Q2 apto Earnings Per Share Basic And Diluted Total
EarningsPerShareBasicAndDilutedTotal
-0.11
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei City Area Code
CityAreaCode
647
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63673000 usd
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2393000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11681000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1699000 usd
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-35447
dei Local Phone Number
LocalPhoneNumber
479-9828
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6521000 usd
dei Security12b Title
Security12bTitle
Common Shares, no par value
dei Trading Symbol
TradingSymbol
APTO
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6016000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
398000 usd
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
459000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9312000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8174000 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3000 usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
788000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022Q2 apto Employee Stock Purchase Plan Maximum Payroll Deduction Percent
EmployeeStockPurchasePlanMaximumPayrollDeductionPercent
0.15 pure
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
CY2022Q2 us-gaap Assets
Assets
64805000 usd
CY2021Q4 us-gaap Assets
Assets
82525000 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1136802
dei Entity Address Address Line1
EntityAddressAddressLine1
251 Consumers Road, Suite 1105
dei Entity Address City Or Town
EntityAddressCityOrTown
Toronto
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
92294734
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40034000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39114000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
22375000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
40014000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1663000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2476000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
121000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
133000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
64193000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
81737000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
281000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
323000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
331000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
465000 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
612000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
115000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
9315000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
8289000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
437441000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
437386000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66955000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4353000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4316000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
10673000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-444553000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-422507000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
13488000 usd
us-gaap Operating Expenses
OperatingExpenses
22173000 usd
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88946000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92234000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
55490000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88915000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
74236000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64805000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82525000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7341000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9831000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14734000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18059000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3332000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3657000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7439000 usd
us-gaap Operating Expenses
OperatingExpenses
29740000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
111000 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
23000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
133000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
50000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-5000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-6000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-7000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
108000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
127000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
43000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10565000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13470000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22046000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29697000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-37000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-37000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10602000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13470000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22083000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29697000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92243000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92243000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88946000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92234000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88915000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
74236000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3293000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22046000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
55490000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
118915000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
160000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8807000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29697000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
98185000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10565000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13470000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22046000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29697000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
779000 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2164000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3293000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8807000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30000 usd
CY2021Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
111000 usd
CY2021Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
117000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
225000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
234000 usd
CY2022Q2 apto Interest On Lease Liabilities
InterestOnLeaseLiabilities
6000 usd
CY2021Q2 apto Interest On Lease Liabilities
InterestOnLeaseLiabilities
12000 usd
apto Interest On Lease Liabilities
InterestOnLeaseLiabilities
13000 usd
apto Interest On Lease Liabilities
InterestOnLeaseLiabilities
25000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5000 usd
CY2022Q2 apto Interest Accrued On Investments
InterestAccruedOnInvestments
-18000 usd
CY2021Q2 apto Interest Accrued On Investments
InterestAccruedOnInvestments
-2000 usd
apto Interest Accrued On Investments
InterestAccruedOnInvestments
-7000 usd
apto Interest Accrued On Investments
InterestAccruedOnInvestments
2000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-599000 usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-124000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-813000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-732000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
20000 usd
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
25000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-12000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
134000 usd
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
140000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
277000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
277000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1249000 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1306000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
694000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
743000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
875000 usd
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1052000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
505000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
181000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7047000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8825000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16692000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19201000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29000 usd
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
85000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
160000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
160000 usd
CY2022Q2 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-10090000 usd
CY2021Q2 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-4999000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-17595000 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
14996000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000 usd
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10066000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4999000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17571000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15013000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-5000 usd
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3043000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3740000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
920000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34050000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36991000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
87083000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39114000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
117393000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40034000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
83343000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40034000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
83343000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
38820000 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1844000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1663000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2476000 usd
us-gaap Use Of Estimates
UseOfEstimates
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"><tbody><tr><td style="width:36pt;"> </td><td style="vertical-align:top;width:18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(c)</p> </td><td style="vertical-align:top;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Significant accounting policies, estimates and judgments:</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 54pt;">During the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2022, </em>there have been <em style="font: inherit;">no</em> changes to our significant accounting policies as described in our Annual Report on Form <em style="font: inherit;">10</em>-K for the fiscal year ended <em style="font: inherit;"> December 31, 2021.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 54pt;">The preparation of the condensed consolidated interim financial statements requires management to make judgments, estimates and assumptions that affect the application of accounting policies and reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting period. Actual outcomes could differ from those estimates. The condensed consolidated interim financial statements include estimates, which, by their nature, are uncertain.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 54pt;">The impacts of such estimates are pervasive throughout the condensed consolidated interim financial statements and <em style="font: inherit;"> may </em>require accounting adjustments based on future occurrences.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 54pt;">The estimates and underlying assumptions are reviewed on a regular basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised and in any future periods affected.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"><tbody><tr><td style="width:36pt;"> </td><td style="vertical-align:top;width:18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(e)</p> </td><td style="vertical-align:top;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Concentration of risk:</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 54pt;">The Company is subject to credit risk from the Company’s cash and cash equivalents and investments. The carrying amount of the financial assets represents the maximum credit exposure. The Company manages credit risk associated with its cash and cash equivalents and investments by maintaining minimum standards of <em style="font: inherit;">R1‑low</em> or A‑low investments and the Company invests only in highly rated corporations and treasury bills, which are capable of prompt liquidation.</p>
CY2022Q2 us-gaap Cash
Cash
592000 usd
CY2021Q4 us-gaap Cash
Cash
294000 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
39442000 usd
CY2022Q2 apto Prepaid Research And Development
PrepaidResearchAndDevelopment
834000 usd
CY2021Q4 apto Prepaid Research And Development
PrepaidResearchAndDevelopment
632000 usd
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
829000 usd
CY2021Q4 apto Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
1860000 usd
CY2020Q4 apto Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
1848000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
91000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12000 usd
CY2022Q2 apto Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
1951000 usd
CY2021Q4 apto Operating Lease Right Of Use Asset Gross
OperatingLeaseRightOfUseAssetGross
1860000 usd
CY2022Q2 apto Amortization Of Rightof Use Assets
AmortizationOfRightofUseAssets
1620000 usd
CY2021Q4 apto Amortization Of Rightof Use Assets
AmortizationOfRightofUseAssets
1395000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
331000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
465000 usd
CY2021Q4 apto Research And Development Liabilities Current
ResearchAndDevelopmentLiabilitiesCurrent
3520000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
614000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
344000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6521000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6016000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
22412000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-37000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22375000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
40014000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
40014000 usd
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
61817000 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
78834000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1371000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2152000 usd
CY2022Q2 apto Research And Development Liabilities Current
ResearchAndDevelopmentLiabilitiesCurrent
4536000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
269000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
140000 usd
CY2022Q2 apto Lessee Operating Lease Liability To Be Paid After Year One
LesseeOperatingLeaseLiabilityToBePaidAfterYearOne
0 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
409000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0514 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0537 pure
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
398000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
459000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
115000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
401000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
574000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
117000 usd
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
129000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
238000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
259000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
134000 usd
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
140000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
277000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
277000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10565000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13470000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22046000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29697000 usd
CY2022Q2 apto Weighted Average Number Of Shares Outstanding Basic And Diluted Total
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedTotal
92243000
CY2021Q2 apto Weighted Average Number Of Shares Outstanding Basic And Diluted Total
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedTotal
88946000
apto Weighted Average Number Of Shares Outstanding Basic And Diluted Total
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedTotal
92234000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10656000
CY2021Q2 apto Earnings Per Share Basic And Diluted Total
EarningsPerShareBasicAndDilutedTotal
-0.15
apto Earnings Per Share Basic And Diluted Total
EarningsPerShareBasicAndDilutedTotal
-0.24
apto Earnings Per Share Basic And Diluted Total
EarningsPerShareBasicAndDilutedTotal
-0.33
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15112000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5625000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.23
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
14000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1567000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.87
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19156000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
17879000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y4M24D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11942000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3156000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.55
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
800000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.67
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14231000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.88
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8001000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
13296000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y9M18D
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5480000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0207 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0043 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.829 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.808 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5625000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3156000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
779000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2164000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3293000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8807000 usd

Files In Submission

Name View Source Status
0001171843-22-005260-index-headers.html Edgar Link pending
0001171843-22-005260-index.html Edgar Link pending
0001171843-22-005260.txt Edgar Link pending
0001171843-22-005260-xbrl.zip Edgar Link pending
apto-20220630.xsd Edgar Link pending
apto-20220630_cal.xml Edgar Link unprocessable
apto-20220630_def.xml Edgar Link unprocessable
apto-20220630_lab.xml Edgar Link unprocessable
apto-20220630_pre.xml Edgar Link unprocessable
apto20220630_10q.htm Edgar Link pending
apto20220630_10q_htm.xml Edgar Link completed
ex_402001.htm Edgar Link pending
ex_402002.htm Edgar Link pending
ex_402003.htm Edgar Link pending
ex_402004.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending